详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Combination of Capecitabine and Temozolomide for Advanced Thymic Neuroendocrine Tumors

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

单位： [1]China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China [2]China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China

出处：

ISSN：

关键词： thymic neuroendocrine tumors capecitabine temozolomide progress-free survival adverse effect

语种：

WOS：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区医学

小类 | 3 区内分泌学与代谢 3 区神经科学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区内分泌学与代谢 3 区神经科学

JCR分区：

出版当年[2016]版：

Q2 NEUROSCIENCES Q2 ENDOCRINOLOGY & METABOLISM

最新[2023]版：

Q2 ENDOCRINOLOGY & METABOLISM Q2 NEUROSCIENCES

影响因子： 最新[2023版] 3.2 最新五年平均[2021-2025] 3.6 出版当年[2016版] 3.608 出版当年五年平均[2012-2016] 4.392 出版前一年[2015版] 2.583 出版后一年[2017版] 5.024

第一作者：

第一作者单位： [1]China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid [2]Capecitabine and Temozolomide as a Promising Therapy for Advanced Thymic Atypical Carcinoid [3]A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study [4]关注制剂中辅料的不良反应 [5]Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps [6]S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial [7]Effect of Yugengtongyu Granules in Patients with Stable Coronary Artery Disease on Reducing Adverse Cardiovascular Events: A Double-Blind Controlled Trial [8]卡培他滨在ⅲ期结直肠癌一线化疗后维持治疗的临床分析 [9]Clinical observation of external compound Chinese herbal extract LC09 with capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer [10]Effect of different expression status of MGMT on the efficacy of temozolomide in gastroenteropancreatic neuroendocrine tumors